Nice and quiet on the threads for the weekend and took a moment to revisit this post from @RNClarke. Another fantastic post from someone who has proven credibility IMO, through a long series of top informative updates and perspective.
Now, with the benefit of hindsight. nViso was ticked off shortly after with an agreement that many see as favourable to both companies, and the growth of ePat. The company announcements will provide more factually based material, but this rundown of the preso gives us a background to the mindset and workings of a fine management team. Without being spoon fed, it provides a good insight into exactly how management see the potential of what we are becoming here (and how they plan to do it).
We have already seen the ability of management to not only meet, but exceed timelines which is a vital part of shareholder confidence. I have been given no reason to doubt the goals and ambitions of the company this far. If we look at a few of the points mentioned above, I can't help but feel excited.
From previous research and reading material where Prof Jeff Hughes was the author, there is no doubt in my mind that the industry is crying out for the app (particularly pain management and identification of those with dementia). Once commercialisation occurs in Aus then we start the attempts to become multinational. There is no telling where we could be if they can pull of the app for pre verbal children. If it takes, these things have a habit of spreading like 'wild fire'.
My confidence in my position continues to grow, regardless of small share price fluctuations.
IMO.
I have really appreciated some of the material posted here. Good luck and patience to all long term holders.
EPT Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held